N/A N=1,260 Suubi4Her: Combination Intervention for Adolescent Girls Transitioning Into Adulthood in Uganda
HIV/AIDS
Primary: Proportion With STIs From Baseline to Follow-up Assessments — 43; 20; 29; 428 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=195 Scaling Community-Clinical Linkage Models to Address Diabetes and Hypertension Disparities in the Southeast United States
Hypertension
Primary: Percentage of Patients Who Achieve Blood Pressure (BP) Control. — 40.2; 24.2 percentage of participants
N/A N=507 Stepped Palliative Care Versus Early Integrated Palliative Care in Patients With Advanced Lung Cancer
Lung Cancer
Primary: Patient-reported Quality of Life — 100.62; 97.75 score on a scale — p=<0.05
Phase 2 N=23 Crossover Trial to Assess Efficacy and Safety of Inhaled AQ001S Compared to a Budesonide Suspension in Mild Asthmatics
Asthma
Primary: Change From Baseline in PC20 After Each Treatment Period Assessed by Methacholine (MCh) Challenge Test — 3.7; 1.2 mg/mL — p=0.000813
N/A N=291 LCI-HEM-SCD-ST3P-UP-001: The Sickle Cell Trevor Thompson Transition Project (ST3P-UP Study)
Sickle Cell Disease
Primary: Acute Care Visits (Visits Per Year) — 2.46; 2.96 visits per year
Phase 1 N=32 Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults
Healthy
Primary: Maximum Observed Concentration (Cmax) of UPB-101 — 11.6; 24.4; 35.1; 34.9 ug/mL
N/A N=4,588 A Prospective "Universal" Observational Database for COVID-19
COVID-19
Primary: Need for Hospitalization — 3389 Participants
Phase 2 N=49 Vaginal Diazepam for the Treatment of Female Pelvic Pain
Pelvic Floor Disorders · Pelvic Pain
Primary: Visual Analog Scale (VAS) for Pain — 50; 39 score on a scale — p=0.62
N/A N=83 Young Men's Health Project Targeting HIV Risk Reduction and Substance Abuse
HIV Infections
Primary: Illicit Drug Use Days — 3.17; 3.10; 3.25; 2.86 Number of Days — p=0.35
N/A N=24 Negative Pressure Wound Therapy-PICO: Cosmesis in Repeat C-Sections
Hypertrophic Skin Condition of Anterior Abdomen
Primary: Subjective Cosmetic Result — 13; 26.5 units on a scale
Phase 3 N=320 Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate
Attention Deficit Hyperactivity Disorder
Primary: Change From Baseline in Severity of Attention Deficit Hyperactivity (ADHD) Symptoms — -11.1; -18.2; -18.1 score on a scale
Phase 1 N=20 BI 409306 Cardiac Safety Trial in Healthy Volunteers
Healthy
Primary: Slope of the Placebo-corrected Change From Baseline of Heart Rate at Rest and Plasma Concentration Between 0 to 10 Hours — 0.80; 5.46 beats/min
N/A N=47 A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Primary: The Number of Patients for Whom Treatment is Feasible. — 40 Participants
N/A N=2,596 Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID)
High Risk Atherosclerotic Cardiovascular Disease
Primary: Proportion of Patients With Intensification of Lipid Lowering Therapy — 159; 142 Participants
Phase 3 N=89 Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Primary: Disease-free Survival (DFS) in FAS (Using Investigator Assessments According to Response Evaluation Criteria in Solid Tumors 1.1 [RECIST 1.1]) — NA; NA months